171 related articles for article (PubMed ID: 16468648)
1. [Tumor cell targetability of folate receptor-mediated mitoxantrone albumin nanoparticles].
Zhang LK; Hou SX; Mao SJ; Wei DP; Song XR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):77-9. PubMed ID: 16468648
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles.
Zhang LK; Hou SX; Zhang JQ; Hu WJ; Wang CY
Arch Pharm Res; 2010 Aug; 33(8):1193-8. PubMed ID: 20803122
[TBL] [Abstract][Full Text] [Related]
3. [Study on the tumor cell targetability of folate-conjugated albumin nanoparticles].
Zhang LK; Hou SX; Mao SJ; Wei DP; Song XR; Qiao XR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):165-8. PubMed ID: 15071905
[TBL] [Abstract][Full Text] [Related]
4. [Study on the preparation of folate-conjugated albumin nanoparticles].
Zhang L; Hou S; Mao S; Song X; Chen T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Apr; 21(2):225-8. PubMed ID: 15143545
[TBL] [Abstract][Full Text] [Related]
5. [Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles].
Zu YG; Yuan S; Zhao XH; Zhang Y; Zhang XN; Jiang R
Yao Xue Xue Bao; 2009 May; 44(5):525-31. PubMed ID: 19618731
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.
Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q
Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959
[TBL] [Abstract][Full Text] [Related]
7. Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
Shi Y; Su C; Cui W; Li H; Liu L; Feng B; Liu M; Su R; Zhao L
J Nanobiotechnology; 2014 Oct; 12():43. PubMed ID: 25358257
[TBL] [Abstract][Full Text] [Related]
8. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo.
Miao FQ; An YL; Yang R; Tang QS; Zhang JQ
Biomed Mater Eng; 2014; 24(1):599-607. PubMed ID: 24211944
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.
Ling G; Zhang T; Zhang P; Sun J; He Z
Drug Dev Ind Pharm; 2016 Aug; 42(8):1351-9. PubMed ID: 26754913
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
[TBL] [Abstract][Full Text] [Related]
12. Folic acid-conjugated nanostructured materials designed for cancer cell targeting.
Pan D; Turner JL; Wooley KL
Chem Commun (Camb); 2003 Oct; (19):2400-1. PubMed ID: 14587701
[TBL] [Abstract][Full Text] [Related]
13. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells.
Zhang L; Hou S; Mao S; Wei D; Song X; Lu Y
Int J Pharm; 2004 Dec; 287(1-2):155-62. PubMed ID: 15541922
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
Lu B; Xiong SB; Yang H; Yin XD; Chao RB
Eur J Pharm Sci; 2006 May; 28(1-2):86-95. PubMed ID: 16472996
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice.
Guo L; Peng Y; Yao J; Sui L; Gu A; Wang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):471-7. PubMed ID: 20735207
[TBL] [Abstract][Full Text] [Related]
16. Design of folic acid-conjugated nanoparticles for drug targeting.
Stella B; Arpicco S; Peracchia MT; Desmaële D; Hoebeke J; Renoir M; D'Angelo J; Cattel L; Couvreur P
J Pharm Sci; 2000 Nov; 89(11):1452-64. PubMed ID: 11015690
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.
Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK
J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692
[TBL] [Abstract][Full Text] [Related]
18. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
19. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
Zaloga J; Feoktystov A; Garamus VM; Karawacka W; Ioffe A; Brückel T; Tietze R; Alexiou C; Lyer S
Colloids Surf B Biointerfaces; 2018 Jan; 161():18-26. PubMed ID: 29035747
[TBL] [Abstract][Full Text] [Related]
20. Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment.
Kunjiappan S; Govindaraj S; Parasuraman P; Sankaranarayanan M; Arunachalam S; Palanisamy P; Mohan UP; Babkiewicz E; Maszczyk P; Vellaisamy S; Panneerselvam T
Nanotechnology; 2020 Apr; 31(15):155102. PubMed ID: 31775133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]